Laporan Laba Rugi (TTM)
Laporan Laba Rugi Zhong Yuan Bio-Technology Holdings Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
| Change (%) | 22.51 | 18.38 | 8.21 | 7.59 | 11.15 | 10.03 | -8.89 | 1.11 | -22.49 | 50.47 | -0.31 | -4.32 | -4.52 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -1.07 | -1.08 | 7.98 | 7.39 | 79.52 | -28.40 | -24.96 | -7.75 | -50.27 | 34.79 | 81.12 | -20.79 | -26.24 | |
| % of Revenue | 25.55 | 20.63 | 17.24 | 17.20 | 17.17 | 27.74 | 18.05 | 14.86 | 13.56 | 8.70 | 7.80 | 14.16 | 11.73 | 9.06 |
| Gross Operating Profit | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Change (%) | 30.60 | 23.43 | 8.26 | 7.63 | -3.03 | 24.78 | -5.34 | 2.65 | -18.14 | 51.96 | -7.20 | -1.61 | -1.63 | |
| % of Revenue | 74.45 | 79.37 | 82.76 | 82.80 | 82.83 | 72.26 | 81.95 | 85.14 | 86.44 | 91.30 | 92.20 | 85.84 | 88.27 | 90.94 |
| SG&A | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 1 |
| Change (%) | 6.34 | 5.96 | 14.04 | 12.31 | 5.68 | 22.19 | -5.55 | 5.27 | 36.51 | -9.29 | -6.86 | -15.93 | -28.92 | |
| % of Revenue | 91.06 | 79.04 | 70.75 | 74.56 | 77.84 | 74.01 | 82.18 | 85.19 | 88.70 | 156.23 | 94.19 | 88.00 | 77.32 | 57.57 |
| R&D | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Change (%) | -7.51 | -8.11 | 1.72 | 1.69 | 105.82 | 51.41 | 17.55 | -4.35 | -31.14 | 1.84 | -49.09 | 71.33 | 5.53 | |
| % of Revenue | 22.02 | 16.62 | 12.90 | 12.13 | 11.47 | 21.23 | 29.22 | 37.69 | 35.66 | 31.68 | 21.44 | 10.95 | 19.61 | 21.68 |
| OpEx | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
| Change (%) | 2.77 | 2.70 | 11.43 | 10.26 | 28.37 | 15.82 | -3.04 | 1.23 | 10.49 | -5.54 | -8.64 | -8.09 | -22.41 | |
| % of Revenue | 138.63 | 116.29 | 100.89 | 103.90 | 106.48 | 122.98 | 129.45 | 137.75 | 137.92 | 196.62 | 123.43 | 113.12 | 108.66 | 88.30 |
| Operating Income | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -2 | -1 | -0 | -0 | 0 |
| Change (%) | -48.32 | -93.52 | 372.37 | 78.83 | 294.37 | 41.04 | 16.80 | 1.57 | 97.46 | -63.51 | -44.20 | -36.81 | -228.97 | |
| % of Revenue | -38.63 | -16.29 | -0.89 | -3.90 | -6.48 | -22.98 | -29.45 | -37.75 | -37.92 | -96.62 | -23.43 | -13.12 | -8.66 | 11.70 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 48.62 | 32.73 | 10.63 | 9.61 | 9.15 | 8.01 | 0.91 | 9.86 | 19.59 | 9.21 | 62.51 | -0.97 | -0.98 | |
| % of Revenue | -1.11 | -1.34 | -1.51 | -1.54 | -1.57 | -1.54 | -1.51 | -1.68 | -1.82 | -2.81 | -2.04 | -3.33 | -3.44 | -3.57 |
| Net Income | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -2 | -2 | -2 | -0 | 0 | 0 |
| Change (%) | -46.76 | -87.82 | 22.22 | 18.18 | 994.48 | 154.08 | 13.74 | 87.00 | -10.22 | -26.78 | -80.72 | -113.26 | 651.04 | |
| % of Revenue | -38.33 | -16.66 | -1.71 | -1.94 | -2.13 | -20.93 | -48.34 | -60.34 | -111.60 | -129.27 | -62.90 | -12.17 | 1.69 | 13.27 |
Source: Capital IQ
